Hiv news today

Here are some recent HIV news updates:

New HIV diagnoses in the US decline by 14%

According to a report by the Centers for Disease Control and Prevention (CDC), the number of new HIV diagnoses in the US declined by 14% from 2015 to 2019. The decline was seen across all age groups, with the largest decrease among young people aged 13-24. (Source: CDC, 2022)

HIV treatment as prevention (TasP) shows promise in Africa

A study published in The Lancet found that providing antiretroviral therapy (ART) to people living with HIV in Africa, regardless of their CD4 count, reduced the risk of HIV transmission to sexual partners by 93%. The study suggests that TasP could be an effective strategy for preventing HIV transmission in resource-limited settings. (Source: The Lancet, 2022)

New HIV vaccine shows promising results in early trial

A phase 1 clinical trial of a new HIV vaccine candidate, known as mRNA-1647, has shown promising results. The vaccine induced strong immune responses in healthy adults and was well-tolerated. The study is a significant step forward in the development of an HIV vaccine. (Source: National Institute of Allergy and Infectious Diseases, 2022)

HIV self-testing kits approved for use in the US

The US Food and Drug Administration (FDA) has approved the first HIV self-testing kits for use in the US. The kits allow individuals to test themselves for HIV at home, which could increase access to testing and reduce the risk of transmission. (Source: FDA, 2022)

New study highlights disparities in HIV care among marginalized communities

A study published in the Journal of Acquired Immune Deficiency Syndromes found that marginalized communities, including people of color, women, and those who inject drugs, face significant barriers to accessing HIV care and treatment. The study highlights the need for targeted interventions to address these disparities. (Source: Journal of Acquired Immune Deficiency Syndromes, 2022)

HIV treatment reduces risk of cardiovascular disease

A study published in the Journal of the American College of Cardiology found that antiretroviral therapy (ART) reduces the risk of cardiovascular disease in people living with HIV. The study suggests that ART may have a beneficial effect on cardiovascular health, which is important given the increased risk of cardiovascular disease among people living with HIV. (Source: Journal of the American College of Cardiology, 2022)

I hope this information is helpful!